XT
LXRX icon

XTX Topco’s Lexicon Pharmaceuticals LXRX Stock Holding History

XTX Topco’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$491K Buy
314,614
+218,524
+227% +$318K 0.01% 2072
2025
Q4 		$111K Sell
96,090
-233,446
-71% -$321K ﹤0.01% 2609
2025
Q3 		$445K Buy
329,536
+263,260
+397% +$299K 0.02% 1162
2025
Q2 		$62.7K Buy
66,276
+53,805
+431% +$34.9K ﹤0.01% 1979
2025
Q1 		$5.75K Buy
+12,471
New +$7.87K ﹤0.01% 2301
2024
Q4 		– Sell
-80,423
Closed -$126K – 2669
2024
Q3 		$126K Buy
+80,423
New +$143K 0.01% 1562
2021
Q2 		– Sell
-14,165
Closed -$83K – 975
2021
Q1 		$83K Buy
+14,165
New +$98.1K 0.04% 582

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco's LXRX Position: Q1 2026 in Review

XTX Topco increased its Lexicon Pharmaceuticals (LXRX) stake by 227% in Q1 2026, buying an estimated $318K and bringing the position to 314,614 shares worth $491K. The position accounts for 0.01% of the portfolio, ranked #2072.

XTX Topco first reported a position in LXRX in Q1 2021 and has held it in 7 quarters since. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • XTX Topco held 314,614 shares of Lexicon Pharmaceuticals worth $491K as of Q1 2026.
  • XTX Topco bought 218,524 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $318K.
  • Lexicon Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2072 holding.
  • XTX Topco first reported a position in Lexicon Pharmaceuticals in Q1 2021 and has held it in 7 quarters since.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.